Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Talsma

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.
International Journal of Pharmaceutics|November 14, 2002
Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-AM Bouma, B Nuijen, G Sava, et al.
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidineB Nuijen, M Bouma, R E Henrar, et al.
Biomaterials|September 29, 2001
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonateJ F Nijsen, M J van Steenbergen, H Kooijman, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Investigational New Drugs|December 16, 1998
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11]J D Jonkman-de Vries, H Rosing, H Talsma, et al.
International Journal of Pharmaceutics|November 14, 2002
Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-AM Bouma, B Nuijen, G Sava, et al.
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidineB Nuijen, M Bouma, R E Henrar, et al.
Biomaterials|September 29, 2001
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonateJ F Nijsen, M J van Steenbergen, H Kooijman, et al.
Drug Development and Industrial Pharmacy|November 11, 2003
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280M Bouma, B Nuijen, R Harms, et al.
Pageof 3